Dissemination of results
Prostate Cancer
PROSTATE CANCER
At the end of the study, once the analysis has taken place and results become available, a summary of research findings will be sent to all participants who request to receive these (there is an item on the ICF where participants can consent to receive the trial results). Results will be disseminated through the scientific community by peer-reviewed publications and conference presentation. We will keep the patient community up to date and involved throughout the entire process through the Prostate Cancer Support Organisation (PCaSO) and other patient support groups and social media.The TMG will form the basis of the Writing Committee and advise on the nature of publications. All publications shall include a list of investigators, and if there are named authors, these should include the chief investigator, co-investigators, trial management team, and statistician(s) involved in the trial. Named authors will be agreed by the CI and director of SCTU. If there are no named authors, then a ‘writing committee’ will be identified.